Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells. (11th September 2014)
- Record Type:
- Journal Article
- Title:
- Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells. (11th September 2014)
- Main Title:
- Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells
- Authors:
- Tacar, Oktay
Indumathy, Sivanjah
Tan, Mei Lin
Baindur‐Hudson, Swati
Friedhuber, Anna M.
Dass, Crispin R. - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="jphp12324-sec-0001" sec-type="section"> <title>Objective</title> <p>Doxorubicin (Dox) is a frontline chemotherapeutic against osteosarcoma (OS) that is plagued by side effects, particularly in the heart. The specific objective of this article is to investigate whether low‐dose Dox treatment had pro‐autophagic effects in cardiomyocytes as well as osteosarcoma cells.</p> </sec> <sec id="jphp12324-sec-0002" sec-type="section"> <title>Methods</title> <p>This study characterises apoptotic (Bax) and autophagic (Beclin‐1) biomarker levels in human OS and cardiomyocyte cell lines as well as in various tissues when mice are exposed to low (1 mg/kg, thrice weekly) and high (3 mg/kg thrice weekly) dose Dox for a month.</p> </sec> <sec id="jphp12324-sec-0003" sec-type="section"> <title>Key findings</title> <p>There was a decrease in Bax and increase in Beclin‐1 in cardiac tissue in the high‐dose group. Dox decreased Beclin‐1 in the skin and liver, with no clear indication in the stomach, small intestine and testis. At low Dox doses of 10 and 100 n<sc>m</sc> in cardiomyocytes and OS cells, there is a pro‐apoptotic effect, with a quicker response in the 100‐n<sc>m</sc> condition, and a slower but steady increase of a pro‐apoptotic response at the lower 10‐n<sc>m</sc> dose. However, electron microscopy images revealed changes to human OS cells that resembled autophagy. Human prostate, breast and colorectal cells treated with<abstract abstract-type="main"> <title>Abstract</title> <sec id="jphp12324-sec-0001" sec-type="section"> <title>Objective</title> <p>Doxorubicin (Dox) is a frontline chemotherapeutic against osteosarcoma (OS) that is plagued by side effects, particularly in the heart. The specific objective of this article is to investigate whether low‐dose Dox treatment had pro‐autophagic effects in cardiomyocytes as well as osteosarcoma cells.</p> </sec> <sec id="jphp12324-sec-0002" sec-type="section"> <title>Methods</title> <p>This study characterises apoptotic (Bax) and autophagic (Beclin‐1) biomarker levels in human OS and cardiomyocyte cell lines as well as in various tissues when mice are exposed to low (1 mg/kg, thrice weekly) and high (3 mg/kg thrice weekly) dose Dox for a month.</p> </sec> <sec id="jphp12324-sec-0003" sec-type="section"> <title>Key findings</title> <p>There was a decrease in Bax and increase in Beclin‐1 in cardiac tissue in the high‐dose group. Dox decreased Beclin‐1 in the skin and liver, with no clear indication in the stomach, small intestine and testis. At low Dox doses of 10 and 100 n<sc>m</sc> in cardiomyocytes and OS cells, there is a pro‐apoptotic effect, with a quicker response in the 100‐n<sc>m</sc> condition, and a slower but steady increase of a pro‐apoptotic response at the lower 10‐n<sc>m</sc> dose. However, electron microscopy images revealed changes to human OS cells that resembled autophagy. Human prostate, breast and colorectal cells treated with 10‐n<sc>m</sc> Dox showed ∼ 40% reduction in cell viability after 24 h.</p> </sec> <sec id="jphp12324-sec-0004" sec-type="section"> <title>Conclusion</title> <p>In culture, cells of both cardiomyocytes and OS revealed a predominant pro‐apoptotic response at the expense of autophagy, although both seemed to be occurring <italic>in vivo</italic>.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of pharmacy and pharmacology. Volume 67:Number 2(2015:Feb.)
- Journal:
- Journal of pharmacy and pharmacology
- Issue:
- Volume 67:Number 2(2015:Feb.)
- Issue Display:
- Volume 67, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 67
- Issue:
- 2
- Issue Sort Value:
- 2015-0067-0002-0000
- Page Start:
- 231
- Page End:
- 243
- Publication Date:
- 2014-09-11
- Subjects:
- Pharmacy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- https://academic.oup.com/jpp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2042-7158 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.ingentaconnect.com/content/rpsgb/jpp ↗ - DOI:
- 10.1111/jphp.12324 ↗
- Languages:
- English
- ISSNs:
- 0022-3573
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5034.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3016.xml